Law360, New York (July 02, 2007, 12:00 AM ET) -- Wyeth has rejected a bid by the plaintiffs in the multidistrict products liability litigation over the hormone drug Prempro to turn over documents related to progestin-free products, arguing that to do so would be prohibitively burdensome and unduly expensive.
The drug maker said in court documents filed June 28 that the plaintiffs' motion to compel the production of the documents should be denied because “the minimal relevance of the data and documents sought in these requests is greatly outweighed by the extreme burden and cost that...
Wyeth Fights Plaintiffs' Bid For Prempro Docs
To view the full article, take a free trial now.
